PDK4 · Western blot design guide

PDK4 Western Blot Planning Guide

Plan a PDK4 Western blot around the catalog-observed 46.5 kDa band, image-backed A02132-1 evidence, HPA controls, and verified protocol records.

Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for PDK4 (PDK4): expected band 46.5 kDa, antibody A02132-1, and guide-derived SDS-PAGE protocol steps
PDK4 Western blot protocol sheet — expected band 46.5 kDa, antibody A02132-1, controls and PMC citations. Open the full PDK4 WB guide →

PDK4 Western Blot Experimental Design Guide

Expected bands, documented protocol parameters, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 46.5 kDa
Observed band Not reported — verify product WB image
Gel 12-15%
Positive control ⓘ Breast
Negative control ⓘ Smooth muscle
Important caveats
Reasons your observed band may differ from the expected size.
ⓘ Calculated mass 46.5 kDa
ⓘ Localization Mitochondrion matrix
ⓘ Processing / PTM Record-dependent
ⓘ Reactivity Human / Mouse / Rat
Section 1

Real Curated PDK4 Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateAdrenal gland
Gel %12-15%
Load20-30 µg total protein per lane
TransferSemi-dry, standard transfer
Membrane0.45 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryA02132-1 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 2

What Is the Expected PDK4 Western Blot Band Size?

Use the product-observed 46.5 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
46.5 kDaMatches the authoritative product WB observation.
46.5 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected PDK4 appearancePlan around 46.5 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band46.5 kDa; use this as the primary experimental expectation.
Calculated mass46.5 kDa from UniProt Q16654; retain as context.
Gel selection12-15%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with A02132-1.
Why is my band missing or off?
SituationLikely causeNext action
46.5 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.

Sample controls for PDK4 Western blot

🧪Use Breast as the first positive-control candidate and Smooth muscle as the HPA Not detected negative candidate.
Positive control: Breast (High)
Negative control: Smooth muscle (Not detected)
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for PDK4

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Positive expression · recommended positive controls

TissueCell typeLevelEvidenceSource
Breast Reported tissue cells High Protein (HPA) HPA →
Adrenal gland Reported tissue cells High Protein (HPA) HPA →
Appendix Reported tissue cells High Protein (HPA) HPA →
Bone marrow Reported tissue cells High Protein (HPA) HPA →

Undetected expression · recommended negative controls

TissueCell typeLevelEvidenceSource
Smooth muscle Reported tissue cells Not detected Protein (HPA) HPA →
Section 3

Advanced PDK4 Western Blot Tips

Deeper troubleshooting and optimisation questions for PDK4, answered from its protein features.

Which band should guide the blot?
Use 46.5 kDa, the observation attached to the authoritative A02132-1 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 46.5 kDa expectation.
Which positive control should I start with?
Start with Breast, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Smooth muscle as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 12-15% consistently across the quick facts, protocol table, and poster.
What transfer method to use for PDK4 Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should A02132-1 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
No verified publication protocol was supplied; use only the deterministic recommended protocol.
Boster reagents

PDK4 Western Blot Reagents

Human/Mouse/Rat-reactive PDK4 Western blot reagents with authoritative product imagery.

Real WB data Western blot validation image for PDK4 using A02132-1; observed band 46.5 kDa
Anti-PDK4 Antibody Picoband®
Cat # A02132-1
Real WB data Western blot validation image for PDK4 using PB9773; observed band 46.5 kDa
Anti-PDK4 Antibody Picoband®
Cat # PB9773

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.

References

  1. UniProt Q16654
  2. Human Protein Atlas — PDK4
  3. A02132-1 product record
  4. PMC6720191 — Transcriptional Response of Subcutaneous White Adipose Tissue to Acute Cold Exposure in Mice (International journal of molecular sciences, 2019)
  5. PMC4930740 — Arsenic silences hepatic PDK4 expression through activation of histone H3K9 methylatransferase G9a (Toxicology and applied pharmacology, 2016)